<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="2336">
  <stage>Registered</stage>
  <submitdate>21/04/2009</submitdate>
  <approvaldate>21/04/2009</approvaldate>
  <nctid>NCT00885404</nctid>
  <trial_identification>
    <studytitle>Chloride High Level Of Resuscitation Infusion Chloride High Level Of Resuscitation Infusion Delivered Evaluation</studytitle>
    <scientifictitle>A Prospective, Before and After Study of the Impact of Lower Chloride Intravenous Fluid Management on Patients' Acid-base Status, Renal Profile,Length of Stay and Mortality.</scientifictitle>
    <utrn />
    <trialacronym>CHLORIDE</trialacronym>
    <secondaryid>2008/03445</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Shock</healthcondition>
    <healthcondition>Critical Illness</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Lower chloride fluids (Hartmann's solution and Plasmalyte速)

Other: Intravenous fluids - 


Treatment: drugs: Lower chloride fluids (Hartmann's solution and Plasmalyte速)
Intravenous fluids used during the 6 month intervention period (after). Amount of fluids to be used is based on clinicians' discretion.

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Mean base excess during hospital stay</outcome>
      <timepoint>Six month control period (before) and 6 month intervention period (after)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Unmeasured anions (strong ion gap) and chloride levels during hospital stay</outcome>
      <timepoint>Six month control period (before) and 6 month intervention period (after)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Serum creatine levels</outcome>
      <timepoint>Six month control period (before) and 6 month intervention period (after)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Length of ICU stay</outcome>
      <timepoint>Six month control period (before) and 6 month intervention period (after)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Length of Emergency Department stay</outcome>
      <timepoint>Six month control period (before) and 6 month intervention period (after)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Length of hospital stay</outcome>
      <timepoint>Six month control period (before) and 6 month intervention period (after)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>In-hospital mortality</outcome>
      <timepoint>Six month control period (before) and 6 month intervention period (after)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  All Intensive Care Unit (ICU) admissions at Austin Hospital

          -  All Emergency Department (ED) admissions at Austin Hospital

          -  All operations at Operating Theatre (OT) with hospital stay of more than 48 hours</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Nil</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/02/2009</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>7000</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate>1/08/2010</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Austin Health - Melbourne</hospital>
    <postcode>3084 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Austin Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to determine whether intravenous fluid management using lower
      chloride solutions (Hartmann's solutions and Plasmalyte速) will result in better outcome when
      compared to management using high chloride solutions (0.9% saline and Gelofusine速).</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00885404</trialwebsite>
    <publication>Stewart PA. How to understand acid-base. A Quantitative Primer for Biology and Medicine. New York: Elsevier, 1981.
Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol. 1983 Dec;61(12):1444-61.
Sirker AA, Rhodes A, Grounds RM, Bennett ED. Acid-base physiology: the 'traditional' and the 'modern' approaches. Anaesthesia. 2002 Apr;57(4):348-56. Review.
Constable PD. Hyperchloremic acidosis: the classic example of strong ion acidosis. Anesth Analg. 2003 Apr;96(4):919-22. Review.
Dorje P, Adhikary G, McLaren ID, Bogush S. Dilutional acidosis or altered strong ion difference. Anesthesiology. 1997 Oct;87(4):1011-2; author reply 1013-4.
Story DA, Liskaser F, Bellomo R. Saline infusion, acidosis, and the Stewart approach. Anesthesiology. 2000 Feb;92(2):624; author reply 626.
Story DA, Poustie S, Bellomo R. Quantitative physical chemistry analysis of acid-base disorders in critically ill patients. Anaesthesia. 2001 Jun;56(6):530-3.
Reid F, Lobo DN, Williams RN, Rowlands BJ, Allison SP. (Ab)normal saline and physiological Hartmann's solution: a randomized double-blind crossover study. Clin Sci (Lond). 2003 Jan;104(1):17-24.
Dorje P, Adhikary G, Tempe DK. Avoiding latrogenic hyperchloremic acidosis--call for a new crystalloid fluid. Anesthesiology. 2000 Feb;92(2):625-6.
Morgan TJ, Venkatesh B, Hall J. Crystalloid strong ion difference determines metabolic acid-base change during in vitro hemodilution. Crit Care Med. 2002 Jan;30(1):157-60.
Kellum JA. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med. 2002 Feb;30(2):300-5.
Morgan TJ, Venkatesh B, Hall J. Crystalloid strong ion difference determines metabolic acid-base change during acute normovolaemic haemodilution. Intensive Care Med. 2004 Jul;30(7):1432-7. Epub 2004 Feb 28.
Story DA, Morimatsu H, Bellomo R. Hyperchloremic acidosis in the critically ill: one of the strong-ion acidoses? Anesth Analg. 2006 Jul;103(1):144-8, table of contents.
</publication>
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Nor'azim Mohd Yunos, MBBS</name>
      <address>Department of Intensive Care, Austin Health</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>